Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,8987 USD | +3,42% | -3,49% | -22,53% |
Vakgebied
Aantal werknemers: 68
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Genetic Diagnostic Testing
100,0
%
| 1 | 100,0 % | 1 | 100,0 % | +69,00% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Germany
100,0
%
| 1 | 100,0 % | 1 | 100,0 % | +69,00% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Guido Baechler
CEO | Chief Executive Officer | 59 | 01-07-21 |
William Caragol
DFI | Director of Finance/CFO | 58 | 01-07-21 |
Corinna Gorges
CTO | Chief Tech/Sci/R&D Officer | - | 01-11-21 |
Chief Tech/Sci/R&D Officer | - | 03-08-22 | |
Moritz Eidens
CTO | Chief Tech/Sci/R&D Officer | 41 | - |
Stefan Erlach
HRO | Human Resources Officer | - | - |
Amy Levin
LAW | General Counsel | - | 29-11-22 |
Jane Edwards
PRN | Corporate Officer/Principal | - | 14-06-22 |
Steve Quinn
PRN | Corporate Officer/Principal | - | 27-01-22 |
Philipp Freese
PRN | Corporate Officer/Principal | 42 | 01-02-15 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gregory Tibbitts
BRD | Director/Board Member | 57 | 14-12-22 |
Heiner Dreismann
CHM | Chairman | 69 | 14-12-22 |
Director/Board Member | 66 | 01-11-21 | |
Guido Baechler
CEO | Chief Executive Officer | 59 | 01-07-21 |
Moritz Eidens
CTO | Chief Tech/Sci/R&D Officer | 41 | - |
Nicole Holden
BRD | Director/Board Member | 51 | 01-11-21 |
Alberto Libanori
BRD | Director/Board Member | 35 | 01-11-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 21 886 575 | 18 256 212 ( 83,41 %) | 0 | 83,41 % |
Bedrijfsgegevens
Mainz Biomed NV
Sirius Gutenberg Park Robert Koch Strasse 50
55129, Mainz
+49 6131 554 2860
http://mainzbiomed.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-22,53% | 19,67 mln. | |
-16,65% | 8,34 mld. | |
+39,98% | 3,59 mld. | |
-32,00% | 2,75 mld. | |
-8,06% | 2,48 mld. | |
-9,47% | 2,32 mld. | |
-13,29% | 1,79 mld. | |
-19,46% | 1,54 mld. | |
-40,57% | 1,21 mld. | |
+9,70% | 1,13 mld. |
- Beurs
- Aandelen
- Koers MYNZ
- Onderneming Mainz Biomed N.V.